Pseudomonas aeruginosa

Pseudomonas aeruginosa is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

MICROBIOLOGY

  • Gram-negative non-fermenting, motile bacillus [Fig 1]; known for blue-green pus due to pyocyanin and pyoverdin pigments.
  • Non-fastidious organism; it can inhabit a variety of environments including soil and water (hot tubs, sinks, water faucets, respirators, disinfectants, and contact lens cleaning solutions).
  • Grows on a wide variety of media. Clinical isolates usually render smooth colonies on plates [Fig 2].
  • Produces biofilm, toxins and proteases.
  • Drug resistance mechanisms include multiple pathways: chromosomal and inducible beta-lactamases, active efflux pumps, acquired genes and plasmid-mediated ESBLs (TEM, SHV, CTX-M), and altered permeability.[11]
    • Carbapenem resistance mechanisms include:
      • Loss of outer membrane porin D (OprD) results in resistance to carbapenems, specifically imipenem.[14]
      • The combined loss of OprD in combination with another mechanism, i.e., overexpression of AmpC beta-lactamase OR overexpression of efflux pumps, is a major determinant of resistance to carbapenems.[10]
      • Production of carbapenemases, esp. Ambler class B metallo-beta-lactamases (NDM, VIM, IMP).[3]
    • Clinical utility of rapid molecular diagnostic platforms to detect genotype resistance to beta-lactam/beta-lactamase inhibitor combinations is limited by the complexity of nontested determinants of beta-lactam resistance, such as OprD changes and drug efflux systems.[6]

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: July 2, 2019